Original Article

Awareness and Knowledge Among Internal Medicine Resident Trainees for Dose Adjustment of Analgesics and Neuropsychotropic Medications in CKD

Authors: Chadi Y. Saad, MD, Joshua Fogel, PhD, Sofia Rubinstein, MD

Abstract

Objectives: Errors in drug dosing lead to poor patient outcomes and are common in patients with chronic kidney disease (CKD). Because the majority of patients with CKD are being treated by physicians specializing in internal medicine, we studied the awareness and knowledge that internal medicine resident trainees (IMRTs) have regarding the correct dosage of commonly used analgesic and neuropsychotropic medications for patients with CKD.

Methods: We surveyed 353 IMRTs about their awareness of whether a medication needs dose adjustment in patients with CKD and knowledge for medication adjustment by level of glomerular filtration rate.

Results: There were high percentages for lack of awareness and knowledge. For analgesics, this lack of awareness/knowledge was highest for acetaminophen (awareness 83.0%, knowledge 90.9%). For neuropsychotropics, this was highest for paroxetine (awareness 74.5%, knowledge 91.5%). Analyses for postgraduate year (PGY) -1 trainees and PGY-2 trainees for analgesics showed higher odds for lack of awareness for tramadol (PGY-1 odds ratio [OR] 2.37, 95% confidence interval [CI] 1.2–4.62, P < 0.05; PGY-2 OR 2.34, 95% CI 1.16–4.72, P < 0.05) and for lack of knowledge for meperedine (PGY-1 OR 4.01, 95% CI 1.81–8.89, P < 0.05; PGY-2 OR 3.30, 95% CI 1.44–7.59, P < 0.05). Nephrology residency rotation for the neuropsychotropic medication of gabapentin showed lower odds for both lack of awareness (OR 0.56, 95% CI 0.32–0.97, P < 0.05) and knowledge (OR 0.52, 95% CI 0.27–0.997, P < 0.05).

Conclusions: Awareness and knowledge are poor among IMRTs for dose adjustments of analgesics and neuropsychotropic medication classes in patients with CKD. There should be a renewed focus during IMRTs’ residency on additional nephrology exposure and formal didactic educational training to help them better manage complex treatment regimens to prevent medication dosing errors.

 

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007;298:2038-2047.
 
2. Drey N, Roderick P, Mullee M, et al. A population-based study of the incidence and outcomes of diagnosed chronic kidney disease. Am J Kidney Dis 2003;42:677-684.
 
3. Fox CS, Larson MG, Leip EP, et al. Predictors of new-onset kidney disease in a community-based population. JAMA 2004;291:844-850.
 
4. Coresh J, Astor BC, Greene T, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003;41:1-12.
 
5. US Renal Data System. Annual data report. https://www.usrds.org/atlas10.aspx. Published 2010. Accessed December 28, 2017.
 
6. Balogun RA, Abdel-Rahman EM, Balogun SA, et al. Association of depression and antidepressant use with mortality in a large cohort of patients with nondialysis-dependent CKD. Clin J Am Soc Nephrol 2012;7:1793-1800.
 
7. Palmer S, Vecchio M, Craig JC, et al. Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int 2013;84:179-191.
 
8. Murtagh FE, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis 2007;14:82-99.
 
9. Murtagh FE, Addington-Hall JM, Edmonds PM, et al. Symptoms in advanced renal disease: a cross-sectional survey of symptom prevalence in stage 5 chronic kidney disease managed without dialysis. J Palliat Med 2007;10:1266-1276.
 
10. Wu J, Ginsberg JS, Zhan M, et al. Chronic pain and analgesic use in CKD: implications for patient safety. Clin J Am Soc Nephrol 2015;10:435-442.
 
11. Rochon PA, Stukel TA, Bronskill SE, et al. Variation in nursing home antipsychotic prescribing rates. Arch Intern Med 2007;167:676-683.
 
12. Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 2007;370:173-184.
 
13. Bergman A, Olsson J, Carlsten A, et al. Evaluation of the quality of drug therapy among elderly patients in nursing homes. Scand J Prim Health Care 2007;25:9-14.
 
14. Hassan Y, Al-Ramahi RJ, Aziz NA, et al. Impact of a renal drug dosing service on dose adjustment in hospitalized patients with chronic kidney disease. Ann Pharmacother 2009;43:1598-1605.
 
15. Institute of Medicine Committee on Identifying and Preventing Medication Errors. Preventing Medication Errors: Quality Chasm Series. Washington, DC: The National Academies Press; 2006.
 
16. Breton G, Froissart M, Janus N, et al. Inappropriate drug use and mortality in community-dwelling elderly with impaired kidney function-the Three-City population-based study. Nephrol Dial Transplant 2011;26:2852-2859.
 
17. Ingrasciotta Y, Sultana J, Giorgianni F, et al. The burden of nephrotoxic drug prescriptions in patients with chronic kidney disease: a retrospective population-based study in Southern Italy. PLoS One 2014;9:e89072.
 
18. Mark TL, Levit KR, Buck JA. Datapoints: psychotropic drug prescriptions by medical specialty. Psychiatr Serv 2009;60:1167.
 
19. Goodwin R, Gould MS, Blanco C, et al. Prescription of psychotropic medications to youths in office-based practice. Psychiatr Serv 2001;52:1081-1087.
 
20. Katon W, von Korff M, Lin E, et al. Adequacy and duration of antidepressant treatment in primary care. Med Care 1992;30:67-76.
 
21. Cole S, Raju M, Barrett J, et al. The MacArthur Foundation Depression Education Program for Primary Care Physicians: background and rationale. Gen Hosp Psychiatry 2000;22:299-358.
 
22. Eisenberg L. Treating depression and anxiety in primary care. Closing the gap between knowledge and practice. N Engl J Med 1992;326:1080-1084.
 
23. Kroenke K, Taylor-Vaisey A, Dietrich AJ, et al. Interventions to improve provider diagnosis and treatment of mental disorders in primary care. A critical review of the literature. Psychosomatics 2000;41:39-52.
 
24. Schurman RA, Kramer PD, Mitchell JB. The hidden mental health network. Treatment of mental illness by nonpsychiatrist physicians. Arch Gen Psychiatry 1985;42:89-94.
 
25. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998;279:1200-1205.
 
26. Long CL, Raebel MA, Price DW, et al. Compliance with dosing guidelines in patients with chronic kidney disease. Ann Pharmacother 2004;38:853-858.
 
27. Ash JS, Sittig DF, Guappone KP, et al. Recommended practices for computerized clinical decision support and knowledge management in community settings: a qualitative study. BMC Med Inform Decis Mak 2012;12:6.
 
28. Physicians’ Desk Reference, 67th ed. Montvale, NJ: PDR Network, 2012.
 
29. UpToDate. Drug information. http://www.uptodate.com. Accessed March 19, 2016.
 
30. US Food and Drug Administration. Acetaminophen information. http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm165107.htm. Accessed March 26, 2016.
 
31. Ryan NM, Isbister GK. Tramadol overdose causes seizures and respiratory depression but serotonin toxicity appears unlikely. Clin Toxicol (Phila) 2015;53:545-550.
 
32. Whelton A. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med 1999;106:13S-24S.
 
33. Cole MG, McCusker J, Elie M, et al. Systematic detection and multidisciplinary care of depression in older medical inpatients: a randomized trial. CMAJ 2006;174:138-144.
 
34. Vadivelu N, Mitra S, Kaye AD, et al. Perioperative analgesia and challenges in the drug-addicted and drug-dependent patient. Best Pract Res Clin Anaesthesiol 2014;l28:91-101.
 
35. Nasca TJ, Philibert I, Brigham T, et al. The next GME accreditation system-rationale and benefits. N Engl J Med 2012;366:1051-1056.
 
36. Clinical Guideline Subcommittee on Low Back Pain, American Osteopathic Association. American Osteopathic Association guidelines for osteopathic manipulative treatment (OMT) for patients with low back pain. J Am Osteopath Assoc 2010;110:653-666.
 
37. Egle JP, Smeenge DM, Kassem KM, et al. The Internet School of Medicine: use of electronic resources by medical trainees and the reliability of those resources. J Surg Educ 2015;72:316-320.
 
38. Agrawal V, Ghosh AK, Barnes MA, et al. Awareness and knowledge of clinical practice guidelines for CKD among internal medicine residents: a national online survey. Am J Kidney Dis 2008;52:1061-1069.
 
39. Bartels C, Goetz S, Ward E, et al. Internal medicine residents’ perceived ability to direct patient care: impact of gender and experience. J Womens Health (Larchmt) 2008;17:1615-1621.
 
40. Nicolai J, Demmel R. The impact of gender stereotypes on the evaluation of general practitioners’ communication skills: an experimental study using transcripts of physician-patient encounters. Patient Educ Couns 2007;69:200-205.
 
41. Lagro-Janssen AL. Medicine is not gender-neutral: influence of physician sex on medical care. Ned Tijdschr Geneeskd 2008;152:1141-1145.
42. Bylund CL, Makoul G. Empathic communication and gender in the physician-patient encounter. Patient Educ Couns 2002;48:207-216.
 
43. Norcini JJ, Boulet JR, Dauphinee WD, et al. Evaluating the quality of care provided by graduates of international medical schools. Health Aff (Millwood) 2010;29:1461-1468.
 
44. Jordan JT, Sellner J, Struhal W, et al. International issues: obtaining an adult neurology residency position in the United States: an overview. Neurology 2014;82:e112-115.
 
45. Smith MA, Cox ED, Bartell JM. Overprescribing of lipid lowering agents. Qual Saf Health Care 2006;15:251-257.
 
46. Accreditation Council for Graduate Medical Education. ACGME Data Resource Book, Academic Year 2012-2013. Chicago: ACGME 2013.